Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;260(4):1161-1169.
doi: 10.1007/s00417-021-05452-1. Epub 2021 Oct 20.

Validation of central serous chorioretinopathy multimodal imaging-based classification system

Collaborators, Affiliations

Validation of central serous chorioretinopathy multimodal imaging-based classification system

Jay Chhablani et al. Graefes Arch Clin Exp Ophthalmol. 2022 Apr.

Erratum in

Abstract

Purpose: Validation of a recently described central serous chorioretinopathy (CSCR) classification system and assessment of levels of agreement among 10 retina physicians.

Methods: This was a cross-sectional (inter-reader agreement) study. Ten retina physicians (assigned a role of masked grader) were provided with a comprehensive dataset of 61 eyes of 34 patients of presumed CSCR. Relevant clinical details and multimodal imaging (fundus autofluorescence, fluorescein and indocyanine green angiography, optical coherence tomography) of both involved and fellow eye were electronically shared. Later, only the fellow eye images were resent to understand the influence of affected eye on the grading of the fellow eye. Multiple inter-grader agreement using Fleiss Kappa was performed to determine the level of agreement among the 10 graders. p value of ≤ 0.05 was considered statistically significant.

Results: Sixty-one eyes of 34 patients were evaluated. There was moderate agreement for major criteria with Fleiss Kappa value of 0.50 (p < 0.0001) with a single outlier observer. After excluding that observer, the Fleiss Kappa value increased to 0.57 (p < 0.0001) with statistically significant p values among all categories, i.e., simple CSC ([Formula: see text] = 0.575), complex CSC ([Formula: see text] = 0.621), and no CSC ([Formula: see text] = 0.452). Overall, moderate to substantial agreement was noted among the subtypes (primary, recurrent, and resolved). The influence of the affected eye on fellow eye grading was studied. The global Fleiss Kappa coefficient ([Formula: see text] = 0.642, p < 0.0001) showed substantial agreement when observers were aware of the affected eye grading. However, without prior available information on the affected eye, the inter-grader agreement was significantly lower (global [Formula: see text] = 0.255, p < 0.0001).

Conclusion: A fair-moderate inter-grader agreement among the masked graders suggests a need for further refinement of this novel classification system. Disease grading should include both eyes as lack of information on affected eye has a bearing on fellow eye grading and inter-grader agreement as shown by a significant difference in global [Formula: see text] values.

Keywords: Central serous chorioretinopathy; Fleiss Kappa coefficient; Fluorescein angiography; Indocyanine green angiography; Inter-rater agreement; Multimodal imaging; Optical coherence tomography.

PubMed Disclaimer

References

    1. Daruich A, Matet A, Dirani A et al (2015) Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82–118 - DOI
    1. Balaratnasingam C, Freund KB, Tan AM et al (2016) Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging. Ophthalmology 123(7):1541–1552 - DOI
    1. Mrejen S, Balaratnasingam C, Kaden TR et al (2019) Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy. Ophthalmology 126(4):576–588 - DOI
    1. Nicholson B, Noble J, Forooghian F et al (2013) Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 58(2):103–126 - DOI
    1. Singh SR, Matet A, van Dijk EHC et al (2019) Discrepancy in current central serous chorioretinopathy classification. Br J Ophthalmol 103(6):737–742 - DOI

LinkOut - more resources